REFERENCES
- Besbas N, Karpman D, Landau D, et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int. 2006; 70: 423–431
- Tschape H, Prager R, Streckel W, Fruth A, Tietze E, Bohme G. Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of hemolytic hemic syndrome in a nursery school: green butter as the infection source. Epidemiol Infect. 1995; 114: 441–450
- Karmali MA, Petric M, Lim C, Fleming PC, Arbus GS, Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985; 151: 775–782
- Hogan MC, Gloor JM, Uhl JR, Cockerill FR, Milliner DS. Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis. 2001; 38: E22–E28
- Chiurchiu C, Firrincieli A, Santostefano M, Fusaroli M, Remuzzi G, Ruggenenti P. Adult nondiarrhea hemolytic uremic syndrome associated with Shiga toxin Escherichia coli O157:H7 bacteremia and urinary tract infection. Am J Kidney Dis. 2003; 41: E4–E8
- Scheutz F, Olesen B, Norgaard A. Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli. Clin Infect Dis. 2000; 31: 815–816
- Miedouge M, Hacini J, Grimont F, Watine J. Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy. Clin Infect Dis. 2000; 30: 395–396
- Carreras L, Romero R, Raquesens C, et al. Familial hypocomplementemic hemolytic uremic syndrome with HLA-A3, B7 haplotype. JAMA. 1981; 245: 602–604
- Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and hemolytic hemic syndrome. Lancet. 2005; 365(9464)1073–1086
- Murinda SE, Batson SD, Nguyen LT, Gillespie BE, Oliver SP. Comparison of Escherichia coli isolates from humans, food, and farm and companion animals for presence of Shiga toxin-producing E. coli virulence markers. Foodborne Pathog Dis. 2004; 1: 178–184
- Petridis M, Bagdasarian M, Waldor MK, Walker E. Horizontal transfer of Shiga toxin and antibiotic resistance genes among Escherichia coli strains in house fly (Diptera: Muscidae) gut. J Med Entomol. 2006; 43: 288–295
- Toth I, Schmidt H, Dow M, Malik A, Oswald E, Nagy B. Transduction of porcine enteropathogenic Escherichia coli with a derivative of a shiga toxin 2-encoding bacteriophage in a porcine ligated ileal loop system. Appl Environ Microbiol. 2003; 69: 7242–7247
- Schmidt H, Bielaszewska M, Karch H. Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7. Appl Environ Microbiol. 1999; 65: 3855–3861
- Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int. 2001; 60: 831–846
- Johnson JR, Jerome C, Boster DR, Stapleton AE, Tarr PI. Analysis of urinary Escherichia coli isolates for ability to produce Shiga toxin. J Clin Microbiol. 2002; 40: 2247–2248
- Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med. 2000; 342: 1930–1936